Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Premature ventricular contraction laboratory findings

Introduction

Overview

Overview

Many cases of premature ventricular contraction have no definite cause, it may be the result of various other problems. If PVC patients present with symptoms, a generalized approach is done to find the precipitating factors.

Laboratory Findings

Laboratory Findings

The following investigations are done to patients with symptoms :

2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)[1]

2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)[1]

Recommendation for Biomarkers

Class IIa
1. In patients with structural heart disease, measurement of natriuretic peptides (BNP or N-terminal pro-BNP) can be useful by adding prognostic information to standard risk factors for predicting SCD or SCA (Level of Evidence: B-NR).[2][3][4][5]

Recommendation for Genetic Counselling

Class I
1. In patients and family members in whom genetic testing for risk stratification for SCA or SCD is recommended, genetic counseling

is beneficial. (Level of Evidence: C-EO).

References

References

  1. ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). “2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death”. Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.
  2. ↑ Scott, Paul A.; Barry, James; Roberts, Paul R.; Morgan, John M. (2009). “Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis”. European Journal of Heart Failure. 11 (10): 958–966. doi:10.1093/eurjhf/hfp123. ISSN 1388-9842.
  3. ↑ Levine, Yehoshua C.; Rosenberg, Michael A.; Mittleman, Murray; Samuel, Michelle; Methachittiphan, Nilubon; Link, Mark; Josephson, Mark E.; Buxton, Alfred E. (2014). “B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias”. Heart Rhythm. 11 (7): 1109–1116. doi:10.1016/j.hrthm.2014.04.024. ISSN 1547-5271.
  4. ↑ Berger, Rudolf; Huelsman, Martin; Strecker, Karin; Bojic, Anja; Moser, Petra; Stanek, Brigitte; Pacher, Richard (2002). “B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure”. Circulation. 105 (20): 2392–2397. doi:10.1161/01.CIR.0000016642.15031.34. ISSN 0009-7322.
  5. ↑ Ahmad, Tariq; Fiuzat, Mona; Neely, Benjamin; Neely, Megan L.; Pencina, Michael J.; Kraus, William E.; Zannad, Faiez; Whellan, David J.; Donahue, Mark P.; Piña, Ileana L.; Adams, Kirkwood F.; Kitzman, Dalane W.; O’Connor, Christopher M.; Felker, G. Michael (2014). “Biomarkers of Myocardial Stress and Fibrosis as Predictors of Mode of Death in Patients With Chronic Heart Failure”. JACC: Heart Failure. 2 (3): 260–268. doi:10.1016/j.jchf.2013.12.004. ISSN 2213-1779.

Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Radwa AbdElHaras Mohamed AbouZaied, M.B.B.S[2] Homa Najafi, M.D.[3] Mugilan Poongkunran M.B.B.S [4]